Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03

Journal of Neuro-Oncology

Volumn 95, Issue 2, 2009, Pages 247-257

  Corn, Benjamin W ^a   Wang, Meihua ^b   Fox, Sherry ^c   Michalski, Jeffrey ^d   Purdy, James ^e   Simpson, Joseph ^f   Kresl, John ^g   Curran, Walter J ^h   Diaz, Aidnag ⁱ   Mehta, Minesh ^j   Movsas, Benjamin ^k  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b RTOG Headquarters   (United States)

^c Cullather Brain Tumor QOL Center Bonsecours Richmond   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g Arizona Oncology Services   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ University of Texas Health Science Center at San Antonio   (United States)

^j UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^k HENRY FORD HOSPITAL   (United States)

more..

Author keywords

GBM; Neurocognition; QOL; Radiation dose

Indexed keywords

CARMUSTINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE; YOUNG ADULT;

EID: 70350033664     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9923-3     Document Type: Article

References (22)

1. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25:867-890. doi: 10.1016/j.ncl.2007.07.002
2. Stupp R, Mason WP, van den Brent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/NEJMoa043330
3. Tsien C, Moughan J, Michalski JM et al (2009) A phase I/II conformal radiation dose escalation study in newly diagnosed patients with glioblastoma multiforme. RTOG trial 98-03. Int J Radiat Oncol Biol Phys 73:699-708. doi: 10.1016/j.ijrobp.2008.05.034
4. Spitzer WO, Dobson AJ, Hall J et al (1981) Measuring the quality of life of cancer patients. A concise QL index for use by physicians. J Chronic Dis 34:585-597. doi: 10.1016/0021-9681(81)90058-8
5. Tangalos EG, Smith GE, Ivnik RJ et al (1996) The mini mental status examination in general medical practice. Clinical utility and acceptance. Mayo Clin Proc 71:829-837. doi: 10.4065/71.9.829
6. Addington-Hall JM, Macdonald LD, Anderson HD (1990) Can the spitzer quality of life index help to reduce prognostic uncertainty in terminal care? BJC 62:695-699
7. Folstein M, Folstein SE, Mchugh PR (1975) "Mini-mental state" a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198. doi: 10.1016/0022-3956(75)90026-6
8. Jacobson NS, Truax P (1991) Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991(59):12-19. doi: 10.1037/0022-006X.59.1.12
9. Crum RM, Anthony JC, Bassett SS et al (1993) Population-based norms for the mini-mental state examination by age and educational level. JAMA 269:2386-2391. doi: 10.1001/jama.269.18.2386
10. Kalbfleish JD, Prentice RL (1980) The statistical analysis of failure time data. John Wiley and Sons, New York, pp 167-169
11. Corn BW, Moughan J, Knisely JPS et al (2008) Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole brain radiotherapy with or without thalidomide on RTOG 01-18. Int J Radiat Oncol Biol Phys 71:71-78
12. Hochberg FH, Slotnick B (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30:172-177
13. Archibald YM, Lunn D, Ruttan LA et al (1994) Cognitive functioning in long-term survivors of high grade glioma. J Neurosurg 80:247-253
14. Wefel JS, Witgert ME, Meyers CA (2008) Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18:121-131. doi: 10.1007/s11065-008-9058-x
15. Meyers CA, Wefel JS (2003) The use of mini-mental status examinations to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557-3558. doi: 10.1200/JCO.2003.07.080
16. Keibert GM, Curran D, Aaronson NK et al (1998) Quality of life after radiation therapy of cerebral low grade gliomas of the adult: Results of a randomized phase III trial on dose response (EORTC Trial 22844). Eur J Cancer 34:1902-1909. doi: 10.1016/S0959-8049(98)00268-8
17. Bosma I, Vos MJ, Heimans JJ et al (2007) The course of neurocognitive functioning in high grade glioma patients. Neuro-oncology 9:53-62. doi: 10.1215/15228517-2006-012
18. Recht L, Glantz M, Chamberlain M, Hsieh CC (2003) Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol 61:127-136. doi: 10.1023/A:1022187502917
19. Schmidinger M, Linzmayer L, Becherer A et al (2003) Psychometric and quality of life assessment in long-term glioblastoma survivors. J Neurooncol 63:55-61. doi: 10.1023/A:1023740303162
20. Sloan JA, Loprinzi CL, Kuross SA et al (1998) Randomized comparison of four tools measuring overall quality of life patients with advance cancer. J Clin Oncol 16:3662-3673
21. Tang V, Rathbone M, Dorsay JP, Jiang S, Harvey D (2008) Rehabilitation in primary and metastatic brain tumors. Impact of functional outcomes on survival. J Neurol 255:820-827. doi: 10.1007/s00415-008-0695-z
22. Keith RA, Granger CV, Hamilton BB, Sherwin FS (1987) The functional independence measure (FIM): A new tool for rehabilitation. Adv Clin Rehabil 1:6-18